Praxis Precision Medicines Inc's Company Valuation
Currency: USD Updated: 2026-06-18
Previous score
9.51
Change
0
The current valuation score of Praxis Precision Medicines Inc is 9.51, ranking 28 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -21.08, which is -99.27% below the recent high of -0.15 and -26.50% above the recent low of -26.67.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.